Kenalog-40 · DIN 01999869 · 200 mg/5 mL · injection suspension-5mL Pk
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Kenalog-40 · DIN 01999869
Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01
Health Canada: Marketed since 2010-11-23 · brand KENALOG-40 INJECTION · ATC H02AB08 TRIAMCINOLONE · form Suspension · route Intra-articular, Intramuscular · ingredients TRIAMCINOLONE ACETONIDE 40 MG/ML · company Bristol-myers squibb canada · schedule Prescription
Kenalog-40: Formulary list price $31.65 per unit (the source does not state the unit; exact figure $31.6500). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01999869)
Source record
DIN 01999869: Kenalog-40
Raw flags: sec3=Y
Item: 680400034; group id 720; item number 1780; lccId None; manufacturer id BQU
Source form: Inj Susp-5mL Pk; strength: 200mg/5mL
Recorded listing: General benefit
Source prices (unrounded): $31.6500; ministry $31.6500
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01999869
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15481
Shortage status: not checked (no credentials)